All In Biotech

Drug Trial Radar · NCT06633016

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Jan 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 230 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

230

Planned (sponsor's estimate)

Start

Sep 20, 2024

Primary completion

Jun 2026

Study completion Jun 2026

Sponsor

Lead sponsor
Autobahn Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Oct 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if ABX-002 added to an existing antidepressant treatment will benefit depression symptoms in adults with moderate to severe major depressive disorder who have had an inadequate response to their antidepressant. This is a double-blind, placebo-controlled, 2-arm, parallel-group, Phase 2 study, randomized 1:1 (ABX-002: placebo). The study will include the following stages: 1. Screening, approximately 35 days 2. 42-day Treatment Period 3. 2-week post dose Safety Follow-up Period 4. 6-month postdose targeted safety follow-up period

Conditions

  • Major Depressive Disorder

Interventions

  • ABX-002Drug

    ABX-002 oral solution in 1-mL cyclic olefin polymer prefilled syringes, taken on an empty stomach first thing in the morning followed by 240 mL (8 oz) of water.

  • PlaceboOther

    Comparator Placebo oral solution in 1-mL cyclic olefin polymer prefilled syringes, taken on an empty stomach first thing in the morning followed by 240 mL (8 oz) of water.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in the 17-item Hamilton Rating Scale for Depression (HAMD-17)Time frame: 6 weeks

Locations

50 sites in 1 country. Site status is shown where the registry gives one.

  • Autobahn Site #131

    Birmingham, Alabama · Recruiting

  • Autobahn Site #132

    Chandler, Arizona · Active not recruiting

  • Autobahn Site #116

    Phoenix, Arizona · Active not recruiting

  • Autobahn Site #136

    Tucson, Arizona · Withdrawn

  • Autobahn Site #150

    Anaheim, California · Recruiting

  • Autobahn Site #113

    Encino, California · Withdrawn

  • Autobahn Site #133

    Encino, California · Withdrawn

  • Autobahn Site #124

    Glendale, California · Recruiting

  • Autobahn Site #140

    Long Beach, California · Recruiting

  • Autobahn Site #121

    Los Alamitos, California · Withdrawn

  • Autobahn Site #117

    Newport Beach, California · Withdrawn

  • Autobahn Site #106

    Oceanside, California · Active not recruiting

  • Autobahn Site #152

    Orange, California · Recruiting

  • Autobahn Site #151

    Rancho Cucamonga, California · Recruiting

  • Autobahn Site #119

    San Jose, California · Recruiting

  • Autobahn Site #126

    Walnut Creek, California · Recruiting

  • Autobahn Site #149

    West Covina, California · Recruiting

  • Autobahn Site #122

    Cromwell, Connecticut · Recruiting

  • Autobahn Site #108

    Brandon, Florida · Recruiting

  • Autobahn Site #110

    Hialeah, Florida · Recruiting

  • Autobahn Site #101

    Jacksonville, Florida · Recruiting

  • Autobahn Site #139

    Lake City, Florida · Active not recruiting

  • Autobahn Site #111

    Miami, Florida · Recruiting

  • Autobahn Site #141

    Miami, Florida · Active not recruiting

  • Autobahn Site #147

    Miami Gardens, Florida · Recruiting

  • Autobahn Site #102

    Orlando, Florida · Active not recruiting

  • Autobahn Site #148

    Tampa, Florida · Recruiting

  • Autobahn Site #123

    Atlanta, Georgia · Active not recruiting

  • Autobahn Site #112

    Decatur, Georgia · Recruiting

  • Autobahn Site #142

    Peachtree Corners, Georgia · Recruiting

  • Autobahn Site #120

    Savannah, Georgia · Active not recruiting

  • Autobahn Site #154

    Elgin, Illinois · Active not recruiting

  • Autobahn Site #137

    Boston, Massachusetts · Recruiting

  • Autobahn Site #138

    Watertown, Massachusetts · Active not recruiting

  • Autobahn Site #127

    Saint Charles, Missouri · Recruiting

  • Autobahn Site #130

    Las Vegas, Nevada · Withdrawn

  • Autobahn Site #129

    Berlin, New Jersey · Recruiting

  • Autobahn Site #105

    Brooklyn, New York · Recruiting

  • Autobahn Site #134

    Brooklyn, New York · Recruiting

  • Autobahn Site #125

    New York, New York · Active not recruiting

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.